JPS5562065A - 2-methyldihydropyridine derivative - Google Patents
2-methyldihydropyridine derivativeInfo
- Publication number
- JPS5562065A JPS5562065A JP13053079A JP13053079A JPS5562065A JP S5562065 A JPS5562065 A JP S5562065A JP 13053079 A JP13053079 A JP 13053079A JP 13053079 A JP13053079 A JP 13053079A JP S5562065 A JPS5562065 A JP S5562065A
- Authority
- JP
- Japan
- Prior art keywords
- formula
- nitrophenyl
- hydroxymethyl
- methyldihydropyridine
- derivative
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/08—Vasodilators for multiple indications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C205/00—Compounds containing nitro groups bound to a carbon skeleton
- C07C205/49—Compounds containing nitro groups bound to a carbon skeleton the carbon skeleton being further substituted by carboxyl groups
- C07C205/56—Compounds containing nitro groups bound to a carbon skeleton the carbon skeleton being further substituted by carboxyl groups having nitro groups bound to carbon atoms of six-membered aromatic rings and carboxyl groups bound to acyclic carbon atoms of the carbon skeleton
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/80—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
- C07D211/84—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen directly attached to ring carbon atoms
- C07D211/90—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D213/54—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
- C07D213/55—Acids; Esters
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
- C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
- C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
- C07D333/06—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to the ring carbon atoms
- C07D333/24—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Heart & Thoracic Surgery (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Cardiology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Urology & Nephrology (AREA)
- Vascular Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Hydrogenated Pyridines (AREA)
- Plural Heterocyclic Compounds (AREA)
- Heterocyclic Compounds Containing Sulfur Atoms (AREA)
- Pyridine Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB7839978 | 1978-10-10 |
Related Child Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP60214152A Division JPS61118366A (ja) | 1978-10-10 | 1985-09-26 | 2−メチルジヒドロピリジン誘導体の中間体 |
Publications (2)
Publication Number | Publication Date |
---|---|
JPS5562065A true JPS5562065A (en) | 1980-05-10 |
JPS6125711B2 JPS6125711B2 (ko) | 1986-06-17 |
Family
ID=10500226
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP13053079A Granted JPS5562065A (en) | 1978-10-10 | 1979-10-09 | 2-methyldihydropyridine derivative |
JP60214152A Granted JPS61118366A (ja) | 1978-10-10 | 1985-09-26 | 2−メチルジヒドロピリジン誘導体の中間体 |
Family Applications After (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP60214152A Granted JPS61118366A (ja) | 1978-10-10 | 1985-09-26 | 2−メチルジヒドロピリジン誘導体の中間体 |
Country Status (10)
Country | Link |
---|---|
JP (2) | JPS5562065A (ko) |
BE (1) | BE879263A (ko) |
CA (1) | CA1117117A (ko) |
CH (1) | CH642353A5 (ko) |
DE (1) | DE2940833A1 (ko) |
FR (1) | FR2438654A1 (ko) |
GB (1) | GB2036722B (ko) |
IT (1) | IT1125469B (ko) |
NL (1) | NL7907482A (ko) |
SE (2) | SE446265B (ko) |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS59190968A (ja) * | 1983-04-05 | 1984-10-29 | バイエル・アクチエンゲゼルシヤフト | 対称性1,4−ジヒドロピリジンジカルボン酸エステルの製造方法 |
JPS6038322A (ja) * | 1983-08-11 | 1985-02-27 | Fujisawa Pharmaceut Co Ltd | ジヒドロピリジンa物質含有易溶性固形製剤 |
WO2005097118A1 (ja) * | 2004-04-05 | 2005-10-20 | Takeda Pharmaceutical Company Limited | アルドステロン受容体拮抗剤 |
Families Citing this family (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
SE7910521L (sv) * | 1979-12-20 | 1981-06-21 | Haessle Ab | Nya 2-metyl-6-substituerade-4-(2,3-disubstituerad fenyl)-1,4-dihydropyridin-3,5-diestrar med hypotesiva egenskaper, samt forfarande for deras framstellning, och farmaceutiska beredningar innehallande desamma |
JPS57175164A (en) * | 1981-04-18 | 1982-10-28 | Banyu Pharmaceut Co Ltd | 1,4-dihydropyridine derivative and its preparation |
EP0080220B1 (en) * | 1981-11-17 | 1986-02-19 | FISONS plc | Dihydropyridines, methods for their production and their formulation and use as pharmaceuticals |
ZA83959B (en) * | 1982-03-10 | 1984-09-26 | Sandoz Ltd | 1,4-dihydropyridine derivatives,their preparation and pharmaceutical compositions containing them |
CH655110A5 (de) * | 1982-09-03 | 1986-03-27 | Otsuka Pharma Co Ltd | Carbostyrilderivate, verfahren zu deren herstellung und arzneimittel, welche diese enthalten. |
GB8412208D0 (en) * | 1984-05-12 | 1984-06-20 | Pfizer Ltd | Quinolone inotropic agents |
GB8431119D0 (en) * | 1984-12-10 | 1985-01-16 | Fujisawa Pharmaceutical Co | Anti-arteriosclerotic composition |
GB8602518D0 (en) * | 1986-02-01 | 1986-03-05 | Wyeth John & Brother Ltd | 1 4-dihydropyridines |
JPS63115890A (ja) * | 1986-10-31 | 1988-05-20 | Nippon Shinyaku Co Ltd | 2位置換1,4−ジヒドロピリジン誘導体 |
ES2043719T3 (es) * | 1987-06-12 | 1994-01-01 | American Cyanamid Co | Administracion de farmacos por via percutanea. |
US5114946A (en) * | 1987-06-12 | 1992-05-19 | American Cyanamid Company | Transdermal delivery of pharmaceuticals |
US5045553A (en) * | 1987-06-24 | 1991-09-03 | Fujisawa Pharmaceutical Company, Ltd. | Pharmaceutical composition for percutaneous drug absorption and percutaneous drug absorption promoter |
EP0322747B1 (en) * | 1987-12-29 | 1994-03-02 | Fujisawa Pharmaceutical Co., Ltd. | A brain neuron protecting agent containing a dihydropyridine compound |
DE3889532T2 (de) * | 1987-12-29 | 1994-08-25 | Fujisawa Pharmaceutical Co | Dihydropyridin-Verbindung zur Verbesserung der Adernausdehnung und Hemmung der Herzhypertrophie. |
CN101987833B (zh) * | 2009-08-04 | 2014-07-30 | 北京利乐生制药科技有限公司 | 尼伐地平晶型及其制备方法 |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB1552911A (en) * | 1975-07-02 | 1979-09-19 | Fujisawa Pharmaceutical Co | 1,4 dihydropyridine derivatives and the preparation thereof |
GB1591089A (en) * | 1976-12-17 | 1981-06-10 | Fujisawa Pharmaceutical Co | 1,4-dihydropyridine derivatives and process for preparation thereof |
DE2658183A1 (de) * | 1976-12-22 | 1978-07-06 | Bayer Ag | In 2-position substituierte 1,4- dihydropyridin-derivate, verfahren zu ihrer herstellung sowie ihre verwendung als arzneimittel |
-
1979
- 1979-09-21 CA CA000336130A patent/CA1117117A/en not_active Expired
- 1979-10-08 BE BE0/197526A patent/BE879263A/fr not_active IP Right Cessation
- 1979-10-08 FR FR7925007A patent/FR2438654A1/fr active Granted
- 1979-10-09 JP JP13053079A patent/JPS5562065A/ja active Granted
- 1979-10-09 NL NL7907482A patent/NL7907482A/nl active Search and Examination
- 1979-10-09 DE DE19792940833 patent/DE2940833A1/de active Granted
- 1979-10-09 SE SE7908367A patent/SE446265B/sv not_active IP Right Cessation
- 1979-10-09 GB GB7935022A patent/GB2036722B/en not_active Expired
- 1979-10-09 IT IT26362/79A patent/IT1125469B/it active Protection Beyond IP Right Term
- 1979-10-10 CH CH912879A patent/CH642353A5/de not_active IP Right Cessation
-
1984
- 1984-02-09 SE SE8400689A patent/SE446096B/sv not_active IP Right Cessation
-
1985
- 1985-09-26 JP JP60214152A patent/JPS61118366A/ja active Granted
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS59190968A (ja) * | 1983-04-05 | 1984-10-29 | バイエル・アクチエンゲゼルシヤフト | 対称性1,4−ジヒドロピリジンジカルボン酸エステルの製造方法 |
JPS6038322A (ja) * | 1983-08-11 | 1985-02-27 | Fujisawa Pharmaceut Co Ltd | ジヒドロピリジンa物質含有易溶性固形製剤 |
JPH0412245B2 (ko) * | 1983-08-11 | 1992-03-04 | Fujisawa Pharmaceutical Co | |
WO2005097118A1 (ja) * | 2004-04-05 | 2005-10-20 | Takeda Pharmaceutical Company Limited | アルドステロン受容体拮抗剤 |
Also Published As
Publication number | Publication date |
---|---|
GB2036722A (en) | 1980-07-02 |
SE446096B (sv) | 1986-08-11 |
GB2036722B (en) | 1982-12-01 |
IT1125469B (it) | 1986-05-14 |
CH642353A5 (de) | 1984-04-13 |
FR2438654A1 (fr) | 1980-05-09 |
IT7926362A0 (it) | 1979-10-09 |
JPS6125711B2 (ko) | 1986-06-17 |
NL7907482A (nl) | 1980-04-14 |
DE2940833A1 (de) | 1980-04-30 |
FR2438654B1 (ko) | 1983-01-14 |
JPS6143343B2 (ko) | 1986-09-26 |
SE8400689L (sv) | 1984-02-09 |
CA1117117A (en) | 1982-01-26 |
SE446265B (sv) | 1986-08-25 |
BE879263A (fr) | 1980-04-08 |
DE2940833C2 (ko) | 1989-01-26 |
SE8400689D0 (sv) | 1984-02-09 |
JPS61118366A (ja) | 1986-06-05 |
SE7908367L (sv) | 1980-04-11 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JPS5562065A (en) | 2-methyldihydropyridine derivative | |
JPS55301A (en) | 1,4-dihydropyridine-3,5-dicarboxylic ester derivative and its preparation | |
JPS5540678A (en) | Dihydropyridine derivative | |
JPS5547695A (en) | Pyrazole phosphate, its preparation, and insecticide and miticide | |
JPS5432460A (en) | Cycloalkylidenemethylphenylacetic acid derivative and their preparation | |
IE840451L (en) | Triazolylpropanols. | |
PL253666A1 (en) | Method of obtaining novel triazole derivatives | |
JPS57200386A (en) | Novel 1,4-dihydropyridine-3,5-dicarboxylic ester derivative and its salts | |
JPS5547656A (en) | 2-(2-substituted aminoethyl)-1,4-dihydropyridine derivative and its derivative | |
ES549298A0 (es) | Un procedimiento para la preparacion de derivados de triazol | |
JPS5251020A (en) | Compositions for combatting pests and mehod of making the same | |
KR860006442A (ko) | 디하이드로피리딘 유도체의 제조방법 | |
JPS56140989A (en) | 1,4-dihydrophyridine-3,5-dicarboxylic ester derivative or its salt | |
IE832553L (en) | Triazoles | |
NO793989L (no) | Fremgangsmaate til fremstilling av et krystallinsk salt av et cefalosporinderivat | |
DE69221897T2 (de) | Herstellung von 2-(pyridyl)ethyl substituierte phosphor-verbindungen | |
JPS5677263A (en) | Preparation of n-substituted imidazole | |
JPS52113970A (en) | Thiadiazoline-type organic phosphates, their preparation, and insectic ide or miticide containing the same | |
IT1102427B (it) | Procedimento per la preparazione di un composto fungicida mediante reazione di alchilazione | |
JPS56166167A (en) | 2-hydroxypropane derivative, its preparation, and its use | |
JPS5278896A (en) | Synthesis of 2-substituted thioadenosines | |
JPS51123823A (en) | A barbituric acid insecticide and tickicide | |
JPS5750972A (en) | Pyridazone derivative, and agricultural and gardening fungicide comprising it as active ingredient | |
JPS51151333A (en) | Compounds using as insecticide and miticide | |
JPS5344575A (en) | Preparation of hydantoin derivatives |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
LAPS | Cancellation because of no payment of annual fees |